Risk-directed Therapy
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Risk-stratified Therapy Based on Molecular Cytogenetic Aberration and Treatment Response in AML (NCT03620955) | Nanfang Hospital, Southern Medical University | 2018-08-10 |
Track Risk-directed Therapy automatically
Every clearance here is in the API, with alerts when new ones post.